Table 1 Patient characteristics.
Characteristics | Values | |
|---|---|---|
Median Age | 67 years (IQR 51–76) | |
Gender | ||
Male | 50 (41.7%) | |
Female | 70 (58.3%) | |
Stage | ||
I–II | 33 (27.5%) | |
III–IV | 87 (72.5%) | |
IPI | ||
0–1 | 32 (26.7%) | |
2 | 20 (16.7%) | |
3 | 33 (27.5%) | |
4–5 | 35 (29.1%) | |
CNS-IPI | ||
0–1 | 32 (26.7%) | |
2 | 19 (15.8%) | |
3 | 29 (24.2%) | |
4–5 | 40 (33.3%) | |
COO | ||
GC | 40 (33.3%) | |
Non-GC | 72 (60.0%) | |
Not available | 8 (6.7%) | |
LDH above ULN | ||
Yes | 69 (57.5%) | |
No | 51 (42.5%) | |
Extranodal sites | ||
Yes | 66 (55.0%) | |
No | 54 (45.0%) | |
Double-expressor lymphoma | ||
Yes | 30 (25.0%) | |
No | 47 (39.2%) | |
Not available | 43 (35.8%) | |